This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Assessing the Need for Preoperative Localization

Janice L. Pasieka, MD; Michael K. McLeod, MD; Norman W. Thompson, MD; Richard E. Burney, MD

Arch Surg. 1992;127(4):442-447.

Abstract
• The purpose of this study was to examine our experience with the diagnosis, surgical approach, and outcomes of surgery for organic hyperinsulinemia in the era of transhepatic venous sampling. During the period from 1978 to 1991, 50 patients were evaluated and treated for hyperinsulinemia at the University of Michigan Medical Center, all of whom underwent preoperative localization. Forty-one patients (82%) had solitary, benign tumors; four (8%) had either multiple tumors or islet cell dysplasia; and five (10%) had metastatic disease. Forty-seven patients underwent laparotomy, and the source of the hyperinsulinemia was found in all patients. In three patients (6%) preoperative localization did not accurately locate the tumor due to technical difficulties with the completion of the studies. Overall, computed tomography localized nine (26%) of 35 tumors. Angiography accurately localized 18 (44%) of 41 tumors. Transhepatic venous sampling localized 34 (94%) of 36 tumors, and was essential to successful surgical treatment in 15 patients. Compared with angiography, transhepatic venous sampling was a more accurate method of localization and should be performed in all patients in whom computed tomography and visceral angiography do not clearly identify the site of disease. Preoperative localization plays a critical role in the surgical treatment of patients with organic hyperinsulinemia and eliminates the need for blind pancreatic resection.

(Arch Surg. 1992;127:442-447)

Author Affiliations
From the Department of Surgery, Division of Endocrine Surgery, University of Michigan, Ann Arbor.

Footnotes
Accepted for publication August 14, 1991.

Reprint requests to Department of General Surgery, University of Michigan, Taubman Health Care Center, 1500 E Medical Center Dr, Ann Arbor, Ml 48109-0331 (Dr Thompson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Localization of Insulinomas to Regions of the Pancreas by Intraarterial Calcium Stimulation: The NIH Experience
Guettier et al.
J. Clin. Endocrinol. Metab. 2009;94:1074-1080.
ABSTRACT | FULL TEXT  

Giant Insulinoma: Case Report and Review of the Literature
Mittendorf et al.
J. Clin. Endocrinol. Metab. 2005;90:575-580.
ABSTRACT | FULL TEXT  

The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
Kaltsas et al.
Endocr. Rev. 2004;25:458-511.
ABSTRACT | FULL TEXT  

Pancreatic Insulinomas: A 15-Year Experience
Lo et al.
Arch Surg 1997;132:926-930.
ABSTRACT